1 Min Read
Nov 9 (Reuters) - Avenue Therapeutics Inc
* Avenue Therapeutics Inc reports third quarter 2017 financial results and recent corporate highlights
* Q3 loss per share $0.30 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.